Multus
London
About Multus
Multus Biotechnology is a global leader in cell culture media design, helping biomanufacturing companies shorten their time to market while improving supply chain security. By combining high-throughput robotic automation and ML, Multus revolutionizes cell culture media development - delivering breakthrough performance and efficiency that were previously unattainable. Multus’ experienced, multi-disciplinary team of scientists and engineers is redefining the future of biomanufacturing. Harnessing the power of biology, automation, and machine learning, we accelerate the creation of high-performance, resource-efficient cell culture media, empowering the global bioeconomy and enabling the next generation of essential therapies, food, and materials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: multus.bio
- Phone: [email protected]
Industries & Categories
Alternative Protein, Artificial Intelligence (AI), Biopharma, Life Science, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/multus-1639 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.